The evaluation of Probiotic lactocare effect on patients with parennial allergic rhinitis

The evaluation of Probiotic lactocare effect on immune responses and clinical manifestation in patients with parennial allergic rhinitis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150716023235N14

Enrollment

Registered

2019-01-14

Start date

2019-02-09

Completion date

Unknown

Last updated

2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis. Other allergic rhinitis

Interventions

Intervention 1: Intervention group:In addition to the usual treatments for allergic rhinitis, Steroids nasal spray Rhinocort, a lactocare probiotic daily that contains strains: lactobacillus casei, l

Eligibility

Sex/Gender

All

Age

5 Years to 50 Years

Inclusion criteria

Inclusion criteria: All patients with parennial allergic rhinitis aged 5 to 5 years old. Who have positive skin tests with aeroallergen. They have to collaborate.

Exclusion criteria

Exclusion criteria: Patients with a history of autoimmune disease. patients who have systemic corticosteroids or immunosuppressive drugs that are effective on the immune system. pregnant women, immunocompromised patients, patients with allergic asthma. malnourished patients patients who have either The reason why you take antibiotics when taking Probiotic.

Design outcomes

Primary

Measure	Time frame
Interleukin 25 ,Quality of life. Timepoint: Before intervention, 6 months after intervention. Method of measurement: quality of life:miniRQLQ and SNOT22 questionnaires, interleukin 25:elisa kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArezoo Faridzadeh

Mashhad University of Medical Sciences

Arezoofaridzadeh@gmail.com+98 51 38049

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026